文献速递消化道肿瘤与早癌消化内镜

特定微生物所致菌血症与后续结直肠癌诊断之间的关联

Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
PubMed 文献 · Gastroenterology · 2018-05-03

该回顾性研究纳入香港13096例无癌症史的成人菌血症患者,比较其与按年龄、性别和合并症匹配的无菌血症对照组的活检证实结直肠癌发生率。结果显示,脆弱拟杆菌、Gallolyticus链球菌、具核梭杆菌、消化链球菌属、败毒梭菌、产气荚膜梭菌和麻疹孪生球菌所致菌血症患者的结直肠癌风险升高,而既往未与结直肠肿瘤关联的微生物所致菌血症未见风险升高。作者认为临床医生应评估这些菌种所致菌血症患者的结直肠肿瘤病变。

要点

  • 脆弱拟杆菌菌血症患者结直肠癌风险升高(HR=3.85,95%CI=2.62-5.64)。
  • Gallolyticus链球菌菌血症患者结直肠癌风险升高(HR=5.73,95%CI=2.18-15.1)。
  • 具核梭杆菌、消化链球菌属、败毒梭菌、产气荚膜梭菌和麻疹孪生球菌菌血症亦与结直肠癌风险升高相关。

核心结论

  • 在因菌血症住院患者的回顾性分析中,后续结直肠癌诊断与脆弱拟杆菌、Gallolyticus链球菌及其他肠道微生物相关。
  • 这些细菌可能因肠道菌群失调和屏障功能紊乱而进入血流。
  • 这些发现支持肠道微生物群特定成员促进结直肠癌发生的模型。
  • 作者认为临床医生应评估这些菌种所致菌血症患者的结直肠肿瘤病变。

研究设计与样本

  • 回顾性研究,收集2006年1月1日至2015年12月31日香港13096例无既往癌症诊断的成人菌血症住院患者(暴露组)数据。
  • 收集既往与结直肠癌相关的肠道微生物(拟杆菌属、梭菌属、丝状菌属、梭杆菌属、孪生球菌属、颗粒链菌属、微小单胞菌属、消化链球菌属、普雷沃菌属、Solobacterium属和链球菌属)数据。
  • 比较暴露组与按年龄、性别和合并症匹配的无菌血症患者(非暴露组)的活检证实结直肠癌发生率。

主要发现

  • 与非暴露组相比,脆弱拟杆菌菌血症患者结直肠癌风险升高(HR=3.85,95%CI=2.62-5.64,P=5.5×10-12)。
  • 与非暴露组相比,Gallolyticus链球菌菌血症患者结直肠癌风险升高(HR=5.73,95%CI=2.18-15.1,P=4.1×10-4)。
  • 与非暴露组相比,具核梭杆菌菌血症患者结直肠癌风险升高(HR=6.89,95%CI=1.70-27.9,P=.007)。
  • 与非暴露组相比,消化链球菌属菌血症患者结直肠癌风险升高(HR=3.06,95%CI=1.47-6.35,P=.003)。
  • 与非暴露组相比,败毒梭菌菌血症患者结直肠癌风险升高(HR=17.1,95%CI=1.82-160,P=.013);产气荚膜梭菌菌血症患者风险升高(HR=2.29,95%CI=1.16-4.52,P=.017);麻疹孪生球菌菌血症患者风险升高(HR=15.2,95%CI=1.54-150,P=.020)。

临床怎么用

  • 作者认为临床医生应评估这些菌种所致菌血症患者的结直肠肿瘤病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Colorectal cancer (CRC) development has been associated with increased proportions of Bacteroides fragilis and certain Streptococcus, Fusobacterium, and Peptostreptococcus species in the intestinal microbiota. We investigated associations between bacteremia from specific intestinal microbes and occurrence of CRC. METHODS: We performed a retrospective study after collecting data on 13,096 adult patients (exposed group) in Hong Kong hospitalized with bacteremia (identified by blood culture test) without a previous diagnosis of cancer from January 1, 2006 through December 31, 2015. We collected data on intestinal microbes previously associated with CRC (genera Bacteroides, Clostridium, Filifactor, Fusobacterium, Gemella, Granulicatella, Parvimonas, Peptostreptococcus, Prevotella, Solobacterium, and Streptococcus). Clinical information, including patient demographics, comorbid medical conditions, date of bacteremia, and bacterial species identified, were collected. The incidence of biopsy-proved CRC was compared between the exposed and unexposed (patients without bacteremia matched for age, sex, and comorbidities) groups. RESULTS: The risk of CRC was increased in patients with bacteremia from B fragilis (hazard ratio [HR] = 3.85, 95% CI = 2.62-5.64, P = 5.5 × 10-12) or Streptococcus gallolyticus (HR = 5.73, 95% CI = 2.18-15.1, P = 4.1 × 10-4) compared with the unexposed group. In addition, the risk of CRC was increased in patients with bacteremia from Fusobacterium nucleatum (HR = 6.89, 95% CI = 1.70-27.9, P = .007), Peptostreptococcus species (HR = 3.06, 95% CI = 1.47-6.35, P = .003), Clostridium septicum (HR = 17.1, 95% CI = 1.82-160, P = .013), Clostridium perfringens (HR = 2.29, 95% CI = 1.16-4.52, P = .017), or Gemella morbillorum (HR = 15.2, 95% CI = 1.54-150, P = .020). We observed no increased risk in patients with bacteremia caused by microbes not previously associated with colorectal neoplasms. CONCLUSIONS: In a retrospective analysis of patients hospitalized for bacteremia, we associated later diagnosis of CRC with B fragilis and S gallolyticus and other intestinal microbes. These bacteria might have entered the bloodstream from intestinal dysbiosis and perturbed barrier function. These findings support a model in which specific members of the intestinal microbiota promote colorectal carcinogenesis. Clinicians should evaluate patients with bacteremia from these species for neoplastic lesions in the colorectum.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Kwong TNY, Wang X, Nakatsu G, et al. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer. Gastroenterology. 2018. PMID: 29729257. doi:10.1053/j.gastro.2018.04.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。